Skip to main content
Watch Insiders
KLRA filings

Corporate insider profile

Adam Koppel Filing Activity

Latest reported as Director / 10% Owner of Kailera Therapeutics, Inc. (KLRA).

Purchase filings
1
Reported companies
1
Net open-market value
$25,000,000
Latest transaction
Apr 20, 2026

Affiliated corporations

Reported company relationships

KLRALatest reported

Kailera Therapeutics, Inc.

Director / 10% Owner

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 20, 2026Kailera Therapeutics, Inc. (KLRA)Director / 10% OwnerOpen Market Purchase1,562,500$16.00$25,000,000